About the Company

[Summary] A century-old national pharmaceutical enterprise

The Xinyi brand, founded in 1916, Shanghai Pharmaceutical Xinyi Pharmaceutical Co., Ltd. (hereinafter referred to as "SPH Xinyi") is currently 100% owned by Shanghai Pharmaceuticals, and is the largest industrial manufacturing enterprise under Shanghai Pharmaceuticals. As a century-old national pharmaceutical enterprise, SPH Xinyi primarily undertakes the social responsibilities of national drug emergency reserve, supporting national and local governments in advancing healthcare reform, and supporting public welfare undertakings.
Currently, SPH Xinyi has become one of the domestic industrial entities with the most complete product varieties and dosage forms. It owns 11 major industrial enterprises, 1 procurement center, 1 municipal-level R&D center, and 2 joint ventures. It holds nearly 1,000 drug approvals, covering 14 major therapeutic areas and 20 dosage forms, and has 2 national Class I new drug products. Among its 405 marketed specifications (including 149 varieties with 270 specifications listed in the newly issued National Essential Medicines List, accounting for nearly half of the chemical essential medicines list). While maintaining its competitive advantage in chemical preparations, Xinyi has also established its leading position nationwide in microecological preparations, as well as four characteristic dosage forms: aerosols, eye drops, soft capsules, and sustained/controlled-release preparations.
SPH Xinyi has successively received multiple honors such as Shanghai High-tech Enterprise and Shanghai Intellectual Property Demonstration Enterprise. In 2011, Bifico was selected as the "National Standard Strain" for microecological preparations, and in 2016 it was designated as the ATCC standard strain in the United States. It is currently being registered with the US FDA as an independent intellectual property product. By 2021, Bifico will be developed into a billion-yuan product.

List of Enterprises:
Shanghai Pharmaceutical Xinyi Pharmaceutical Co., Ltd.
Shanghai Pharmaceutical Xinyi Pharmaceutical Co., Ltd. No.1 Pharmaceutical Plant
Shanghai Pharmaceutical Xinyi Pharmaceutical Co., Ltd. No.2 Pharmaceutical Plant
Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd.
Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
Shanghai Fuda Pharmaceutical Co., Ltd.
Shanghai Xinyi Wanxiang Pharmaceutical Joint-stock Co., Ltd.
Shanghai Hefeng Pharmaceutical Co., Ltd.
Shanghai Pharmaceutical Group Xinyi Yangpu Co., Ltd.
Shandong Xinyi Pharmaceutical Co., Ltd.
Tianjin Jinjin Pharmaceutical Co., Ltd.
Gansu Xinyi Tiansen Pharmaceutical Co., Ltd.

Email: hr_recruitment@*

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

SPH Xinyi Recruitment Overview / Current Status (5 open positions)

Manage
Note: How fast is hiring at Shanghai Pharmaceutical Xinyi Pharmaceutical Co., Ltd. growing? . A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

SPH Xinyi Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 119,161.1312万(元)
Legal Representative: 毛毅斌
Date Established:
Credit Code: 91310000133742534B
Registered Address: 中国(上海)自由贸易试验区新金桥路905号

Partners & Suppliers

上海上药信谊药厂有限公司通过上药控股有限公司进行药品分销,上药控股是其重要客户。 Source
合作客户 医药分销
双方在利拉鲁肽注射液等产品的市场推广与开发领域建立战略合作 Source
供应商 多肽药物战略合作
采购创志科技固体制剂生产设备 Source
供应商 制药设备-固体制剂

People who follow SPH Xinyi also follow

SPH Xinyi Competitors (Similar Companies)

医药 制药/药业 生物制品 医药工业
“Provides consulting and services to over one hundred pharmaceutical ma”
“A national modern pharmaceutical supply chain service enterprise with ”
微生态 国内电商 电子商务
制药/药业 生产 医药 中成药
“Making safe food, brewing better taste”
制药/药业 医药 医药工业 药物研发
农产品 营养食品 农产品深加工 杂粮
制药/药业 医药 医药工业 生产
仪器/仪表 成套设备 计量仪表 燃气表
“A high-tech enterprise specializing in the research, development, prod”
医药 维生素 处方药
“After more than two decades of development, it has grown into a group ”
医药 生物信息 新药研发 CRO
“Multinational pharmaceutical enterprise”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates